{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:45:27Z","timestamp":1794609927260,"version":"4.9.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100009098","name":"Japanese Respiratory Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009098","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gunma Foundation for Medicine and Health Science"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive (MDA5+) dermatomyositis patients exhibit a variety of clinical features. We therefore investigated whether patterns of B-cell epitope recognition are linked to the clinical course of MDA5+ dermatomyositis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our cross-sectional study used ELISA-based methods to determine the relationship between antibody recognition of overlapping 155 amino acid MDA5 subfragments and clinical features of 24 MDA5+ myositis patients. Correlations between clinical features and standardized anti-MDA5 subfragment antibody titres were assessed via Spearman\u2019s rank correlation coefficients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-four MDA5+ patients submitted serum samples within a median of 0 (interquartile range, 0\u201374) days from the initial clinic visit. In addition to typical dermatomyositis rashes, these patients exhibited muscle symptoms (n\u2009=\u200911), vascular dysfunction (n\u2009=\u20099) and interstitial lung disease (ILD) (n\u2009=\u200916). Female patients exhibited higher titres of antibodies recognizing fragment H (aa 905\u20131026) compared with male patients. Muscle involvement was associated with higher levels of anti-fragment F (aa 646\u2013801) antibody. Conversely, patients with vascular abnormalities had higher anti-fragment B (aa 130\u2013284) and E (aa 517\u2013671) antibody titres than those without vascular dysfunction. Four patients died due to ILD progression and showed higher anti-fragment A (aa 1\u2013155) antibody titres than the other 20 patients. Differences in the ratio of anti-fragment to anti-full-length MDA5 antibody titres were found for sex (H: anti-MDA5) and vascular dysfunction (anti-fragment B, E: anti-MDA5).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Various clinical features of MDA5+ dermatomyositis correlated with levels of antibodies targeting selected subfragments of this autoantigen, providing a link between fragment-specific immune responses and disease course.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead550","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T11:30:12Z","timestamp":1696937412000},"page":"2016-2023","source":"Crossref","is-referenced-by-count":8,"title":["Correlation between B-cell epitope profile and clinical features of anti-MDA5 antibody-positive dermatomyositis"],"prefix":"10.1093","volume":"63","author":[{"given":"Koichi","family":"Yamaguchi","sequence":"first","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, Gunma University Graduate School of Medicine , Gunma, Japan"},{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Poland","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tissa","family":"Bijoy George","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem","family":"Saygin","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"Moghadam-Kia","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester V","family":"Oddis","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1387-0860","authenticated-orcid":false,"given":"Dana P","family":"Ascherman","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"key":"2024070114083558500_kead550-B1","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2024070114083558500_kead550-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2024070114083558500_kead550-B3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.rmed.2015.07.004","article-title":"Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140\/MDA5 antibody positive amyopathic dermatomyositis","volume":"109","author":"Takada","year":"2015","journal-title":"Respir Med"},{"key":"2024070114083558500_kead550-B4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","article-title":"The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody","volume":"49","author":"Nakashima","year":"2010","journal-title":"Rheumatology"},{"key":"2024070114083558500_kead550-B5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2024070114083558500_kead550-B6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/acr.22728","article-title":"Anti\u2013melanoma differentiation\u2013associated gene 5 is associated with rapidly progressive lung disease and poor survival in US patients with Amyopathic and Myopathic dermatomyositis","volume":"68","author":"Moghadam-Kia","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2024070114083558500_kead550-B7","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatology"},{"key":"2024070114083558500_kead550-B8","doi-asserted-by":"crossref","first-page":"773352","DOI":"10.3389\/fimmu.2021.773352","article-title":"Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies","volume":"12","author":"Nombel","year":"2021","journal-title":"Front Immunol"},{"key":"2024070114083558500_kead550-B9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-015-0532-1","article-title":"Role of Jo-1 in the immunopathogenesis of the anti-synthetase syndrome","volume":"17","author":"Ascherman","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"2024070114083558500_kead550-B10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.2008.091405","article-title":"Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies","volume":"68","author":"Krystufkov\u00e1","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2024070114083558500_kead550-B11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"New Engl J Med"},{"key":"2024070114083558500_kead550-B12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/art.41105","article-title":"Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti\u2013melanoma differentiation\u2013associated gene 5\u2013positive dermatomyositis","volume":"72","author":"Tsuji","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2024070114083558500_kead550-B13","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.rmed.2011.05.006","article-title":"HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody","volume":"105","author":"Tanizawa","year":"2011","journal-title":"Respir Med"},{"key":"2024070114083558500_kead550-B14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiol.2462070712","article-title":"Fleischner Society: glossary of terms for thoracic imaging","volume":"246","author":"Hansell","year":"2008","journal-title":"Radiology"},{"key":"2024070114083558500_kead550-B15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.rmed.2013.01.014","article-title":"The prognostic value of HRCT in myositis-associated interstitial lung disease","volume":"107","author":"Tanizawa","year":"2013","journal-title":"Respir Med"},{"key":"2024070114083558500_kead550-B16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12016-020-08814-5","article-title":"Predictive features and clinical presentation of interstitial lung disease in inflammatory myositis","volume":"60","author":"Vojinovic","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"2024070114083558500_kead550-B17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjd.14882","article-title":"Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis","volume":"176","author":"Matsushita","year":"2017","journal-title":"Br J Dermatol"},{"key":"2024070114083558500_kead550-B18","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/acr.21728","article-title":"Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti\u2013melanoma differentiation\u2013associated gene 5 antibody","volume":"64","author":"Cao","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2024070114083558500_kead550-B19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/rheumatology\/key420","article-title":"Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease","volume":"58","author":"Takanashi","year":"2019","journal-title":"Rheumatology"},{"key":"2024070114083558500_kead550-B20","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.4049\/jimmunol.1203070","article-title":"Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase\u2013induced myositis","volume":"191","author":"Fernandez","year":"2013","journal-title":"J Immunol"},{"key":"2024070114083558500_kead550-B21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaut.2007.07.005","article-title":"Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation","volume":"29","author":"Katsumata","year":"2007","journal-title":"J Autoimmun"},{"key":"2024070114083558500_kead550-B22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.21992","article-title":"Anti\u2013melanoma differentiation\u2013associated protein 5\u2013associated dermatomyositis: expanding the clinical spectrum","volume":"65","author":"Hall","year":"2013","journal-title":"Arthritis Care Res"},{"key":"2024070114083558500_kead550-B23","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","article-title":"Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases","volume":"95","author":"Allenbach","year":"2020","journal-title":"Neurology"},{"key":"2024070114083558500_kead550-B24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.55563\/clinexprheumatol\/df2oc3","article-title":"Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses","volume":"40","author":"Yang","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2024070114083558500_kead550-B25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.42308","article-title":"Identification of three different phenotypes in anti-MDA5 antibody-positive dermatomyositis patients: implications for rapidly progressive interstitial lung disease prediction","volume":"75","author":"Xu","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2024070114083558500_kead550-B26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/mr\/roac091","article-title":"Differences in sex-and age-associated mortality in patients with anti-MDA5-positive dermatomyositis","volume":"33","author":"He","year":"2023","journal-title":"Modern Rheumatol"},{"key":"2024070114083558500_kead550-B27","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.24993","article-title":"The long-term outcome and prognosis factor of patients with idiopathic inflammatory myopathies based on myositis-specific autoantibodies","volume":"75","author":"Jiang","year":"2023","journal-title":"Arthritis Care Res"},{"key":"2024070114083558500_kead550-B28","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/acr.21985","article-title":"Utility of anti\u2013melanoma differentiation\u2013associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis","volume":"65","author":"Chen","year":"2013","journal-title":"Arthritis Care Res"},{"key":"2024070114083558500_kead550-B29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.resinv.2018.07.007","article-title":"Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis","volume":"56","author":"Sakamoto","year":"2018","journal-title":"Respir Invest"},{"key":"2024070114083558500_kead550-B30","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/rheumatology\/kex188","article-title":"Clinical characteristics and change in the antibody titres of patients with anti-MDA5 antibody\u2013positive inflammatory myositis","volume":"56","author":"Abe","year":"2017","journal-title":"Rheumatology"},{"key":"2024070114083558500_kead550-B31","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/rheumatology\/keac627","article-title":"Changes in anti-MDA5 antibody titres and serum cytokine levels before and after diagnosis of anti-MDA5 antibody-positive dermatomyositis","volume":"62","author":"Kogami","year":"2023","journal-title":"Rheumatology"},{"key":"2024070114083558500_kead550-B32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11926-018-0798-1","article-title":"Anti-MDA5 antibody spectrum in western world","volume":"20","author":"Moghadam-Kia","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"2024070114083558500_kead550-B33","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/rheumatology\/key060","article-title":"Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients","volume":"57","author":"Sato","year":"2018","journal-title":"Rheumatology"},{"key":"2024070114083558500_kead550-B34","doi-asserted-by":"crossref","first-page":"e001202","DOI":"10.1136\/rmdopen-2020-001202","article-title":"Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease","volume":"6","author":"Nishina","year":"2020","journal-title":"RMD Open"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead550\/52633167\/kead550.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/7\/2016\/58378134\/kead550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/7\/2016\/58378134\/kead550.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T13:59:11Z","timestamp":1719842351000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/7\/2016\/7303861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,10,10]]},"published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead550","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2023,10,10]]}}}